• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL1900091 SB12 eculizumab Injection Biological Products Import Drug Application 2019-09-23 Samsung Bioepis Co., Ltd. Samsung Bioepis Co Ltd In Review 2019-09-21 view
JYSB1900139 依库珠单抗注射液 eculizumab Injection Biological Products Supplementary Application 2019-07-05 杭州泰格医药科技股份有限公司 Hangzhou Tigermed Consulting Co Ltd In Review 2019-07-04 view
JXSL1700032 依库珠单抗注射液 eculizumab Injection Biological Products Import Drug Application 2017-06-22 杭州泰格医药科技股份有限公司 Hangzhou Tigermed Consulting Co Ltd Certificate Issued 2018-09-10 view
JXSL1200054 依库珠单抗注射液 eculizumab Injection Biological Products Import Drug Application 2012-07-10 杭州泰格医药科技股份有限公司 Hangzhou Tigermed Consulting Co Ltd Certificate Issued 2016-04-21 view
JYSZ2200055 依库珠单抗注射液 eculizumab Injection Biological Products License Renew 2022-10-19 view
JYSB2300165 依库珠单抗注射液 eculizumab Injection Biological Products Supplementary Application 2023-09-19 view
JYSB2200186 依库珠单抗注射液 eculizumab Injection Biological Products Supplementary Application 2022-09-27 view
JYSB2300025 依库珠单抗注射液 eculizumab Injection Biological Products Supplementary Application 2023-02-11 view
JXSS2200041 依库珠单抗注射液 eculizumab Injection Biological Products(3.1) Import Drug Application 2022-12-24 view
JXSS2200023 依库珠单抗注射液 eculizumab Injection Biological Products(3.1) Import Drug Application 2022-07-18 view
JYSB2101213 依库珠单抗注射液 eculizumab Injection Biological Products Supplementary Application 2022-01-12 view
JYSB2400075 依库珠单抗注射液 eculizumab Injection Biological Products Supplementary Application 2024-04-04 view